Wake Forest University Health Sciences
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Wake Forest University Health Sciences sits in the top decile of US sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count).
Wake Forest University Health Sciences: 1,140 sponsored US clinical trials, 174 recruiting.
Wake Forest University Health Sciences sponsors 1,140 registered US clinical trials on ClinicalTrials.gov, 174 of them currently recruiting, and 724 completed. 111 of these trials are in Phase 3-4 (later-stage) and 239 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 9 trials.
Top-decile sponsor footprint
Wake Forest University Health Sciences ranks in the top decile of sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
724 of 885 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,140 total, page 7 of 23
Perioperative Continuous Glucose Monitoring
NCT05937373
Pilot Trial of an Online Pain Coping Skills Training Program in Spanish
NCT05917171
CGM Utilization With IV Insulin EndoTool and Subcutaneous Insulin in the Neuro ICU
NCT05857007
Evaluating the Optimal Volume Voided for Passage of a Backfill-Assisted Voiding Trial Following Urogynecologic Surgery
NCT05820139
BurstDR Stimulation for Painful Diabetic Neuropathy
NCT05985291
Dragon Ambient eXperience (DAX) Copilot Evaluation
NCT06329427
Telemedicine Management of Hypertension
NCT05424744
A Study of Hookah Café Customers in the Atlanta Area
NCT05916170
Trial to Address Food Insecurity in Patients With Hypertension (SMART-FI)
NCT05800145
Rural Area Pharmacist Intervention for Diabetes
NCT05761886
Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy
NCT05597878
Auricular Acupressure as a Non-Opioid Adjuvant in Opioid Tolerant Patients
NCT05711537
Pecto-intercostal Fascial Block (PIFB) for Postop Analgesia Following Sternotomy in Cardiac Surgery Patients
NCT05676814
RECELL to Promote Healing Following Carbon Dioxide (CO2) Laser Treatment in Cosmetic Patients
NCT05386368
Food Addiction Clinical Treatment Program
NCT04373343
Effects of Intravenous (IV) Omadacycline on Gut Microbiome
NCT05515562
Arena Labs - Improving Clinician Well Being
NCT05653700
Comparison of Text and Pictorial Waterpipe Tobacco Warnings Among Young Adults
NCT05783843
EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders)
NCT05742841
Tourette Discrimination (TD) Stigma Scale
NCT05696769
Complex And Simple Appendicitis: REstrictive or Liberal Post-operative Antibiotic eXposure (CASA RELAX) - Atrium Health
NCT05746520
A Pharmacokinetic Study of Intravenous and Intranasal Oxytocin in Healthy Subjects
NCT05672667
Steps for Epilepsy
NCT05359003
COVID-19 Testing and Vaccination Among Spanish Speakers
NCT05302908
Validation and Implementation Design of an Epic Systems 30-day Unplanned Readmission Risk Model
NCT05413889
The Effects of Sedatives on Tobacco Use Disorder Version 2
NCT05505630
Monocyte Priming When Consuming a Western Diet
NCT05348395
Carotid Ultrasound to Identify Head and Neck Cancer Survivors With High Cardiovascular Risk After Radiation Therapy
NCT05490875
Diltiazem in the Treatment of Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Rate
NCT05661942
Transversus Abdominis Plane (TAP) Block Using Liposomal Bupivacaine in Metabolic and Bariatric Surgery Patients
NCT05537883
Quantifying the Venous Congestion Curve of a Tissue Oximetry Device
NCT05592145
Consumer Perceptions of Waterpipe Tobacco Packaging and Digital Marketing Claims
NCT05439421
Telehealth-Enhanced Assessment and Management After Stroke-Blood Pressure
NCT05539443
Mastectomy Flap Temperature Study
NCT05395936
Trial of the Impact of the Electronic Frailty Integrated With Social Needs
NCT05293730
Effects of Smoking State on Decision Making
NCT04826276
Cranial Ultrasound for Prehospital ICH Diagnosis
NCT05492474
Adolescents Living With HIV (ALWH): Social Networks, Adherence and Retention
NCT04077047
Child Health Improvement Through Computer Automation - Child Neurology (CHICA-CN) Evaluation
NCT05173506
Improving Disease Severity
NCT05391178
Cigarette and E-cigarette Nicotine Content in an Electronic Tobacco Marketplace (ETM)
NCT05320887
A Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia
NCT05759338
The Effects of Animal Assisted Therapy in Outpatient Psychiatry Clinics
NCT05326074
Health, Aging and Later-Life Outcomes
NCT05424042
At Home Early vs. Delayed Catheter Removal Following Failed Postoperative Voiding Trial: a Randomized Trial
NCT05353400
Radiofrequency Hyperthermia Safety Study
NCT05399771
PENG Block Versus LP Block for THA Postop Pain
NCT05261009
Expanding Health System Intervention Through The Women, Infants and Children (WIC) Program Partnership
NCT05356338
Well-Child Visit Trial
NCT05086237
Dose Ranging Study of Intravenous Oxytocin for Analgesia to Heat Pain
NCT05179421
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 96 |
| Phase 2 | 143 |
| Phase 3 | 31 |
| Phase 4 | 80 |
Therapeutic Areas
What is open in the Wake Forest University Health Sciences pipeline
174 recruiting of 1,140 indexed (15% open); 724 completed (64%).
Phase mix: 111 late (III/IV) vs 239 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Wake Forest University Health Sciences: open-pipeline peers nationwide
Peers matched on 1,140 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Wake Forest University Health Sciences sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,140 trials (± recruiting share)
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- University of Florida · 1,106 trials · 15% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Baylor University · 15% recruiting · 33 trials
- Cornell University · 15% recruiting · 66 trials
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
Related
What to do with this Wake Forest University Health Sciences page
1,140 registered trials is a research-attention snapshot, not an endorsement of Wake Forest University Health Sciences or any single study.
- 174 of Wake Forest University Health Sciences's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Wake Forest University Health Sciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Wake Forest University Health Sciences pipeline card: 1,140 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.